The information highlighted (if any) are the most recent updates for this brand.
A foreign epidemiological study of vitamin A in pregnant women suggested an increased frequency of birth defects dominated by cranial neural crest defects in newborns delivered by women administered 10,000 IU/day or higher amounts of vitamin A during 3 months prior to pregnancy and the first 3 months of pregnancy. When AMINOLEBAN EN powder is administered to pregnant women during the first 3 months of pregnancy or women who have an intention to become pregnant, special attention should be paid to dosage, adjusting as necessary to achieve a reduction to less than 5,000 IU/day of vitamin A.